4Muller M,Scheffold C,Lefterova P,et al.Potential of autologous immunologic effector cells for prediction of progression of disease in patients with chronic myelogenous leukemia. Leukemia and Lymphoma . 1998
5Mehta BA,Schmidt-Wolf IG,Weissman IL,et al.Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD+3 CD+56 killer cells. Blood . 1995
6Ma Y, Zhang Z, Tang L, et al. Cytokine-induced killer cells in thetreatment of patients with solid carcinomas: a systematic review andpooled dialysis. Cytotherapy, 2012, 14(4):483-493.
7Ma Y, Xu YC, Tang L, et al. Cytokine-induced killer (CIK) celltherapy for patients with hepatocellular carcinoma: efficacy and safety.Exp Hematol Oncol, 2012,1(1):11.
8Li R, Wang C, Liu L, et al. Autologous cytokine-induced killer cellimmunotherapy in lung cancer: a phase II clinical study. CancerImmunol Immunother, 2012,61(11):2125-2133.
9Yu X, Zhao H, Liu L, et al. A randomized phase II study of autologous cytokine-induced killer cells in treatment of hepatocelluar carcinoma. J Clin Immunol, 2014, 34(2): 194-203.
10Liu L, Zhang W, Qi X,et al. Randomized study of autologouscytokine-induced killer cell immunotherapy in metastatic renalcarcinoma. Clin Cancer Res, 2012,18(6):1751-1759.
